GlycoMimetics
GLYC
#10327
Rank
โ‚ฌ8.7 M
Marketcap
0,13ย โ‚ฌ
Share price
-5.42%
Change (1 day)
-50.78%
Change (1 year)

GlycoMimetics (GLYC) - Total assets

Total assets on the balance sheet as of March 2025 : โ‚ฌ5.14 Million

According to GlycoMimetics 's latest financial reports the company's total assets are โ‚ฌ5.14 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

GlycoMimetics - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ10.65 M-74%
2023-12-31โ‚ฌ40.99 M-15.13%
2022-12-31โ‚ฌ48.3 M-42.02%
2021-12-31โ‚ฌ83.3 M-28.26%
2020-12-31โ‚ฌ0.11 B-22.55%
2019-12-31โ‚ฌ0.14 B-20.16%
2018-12-31โ‚ฌ0.18 B75.24%
2017-12-31โ‚ฌ0.10 B165.93%
2016-12-31โ‚ฌ40.29 M-9.08%
2015-12-31โ‚ฌ44.32 M-5.87%
2014-12-31โ‚ฌ47.08 M1130.7%
2013-12-31โ‚ฌ3.82 M-72.53%
2012-12-31โ‚ฌ13.92 M-37.45%
2011-12-31โ‚ฌ22.26 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
bluebird bio
BLUE
โ‚ฌ0.25 B 4,839.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ179.27 B 3,483,290.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ130.83 B 2,541,946.47%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
โ‚ฌ165.60 B 3,217,693.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ3.2 M-37.78%๐Ÿ‡บ๐Ÿ‡ธ USA